These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 19928377)

  • 1. Rebound hypersomnolence, stimulant abuse, and DAT-mediated dopamine release.
    Nishino S
    Sleep; 2009 Nov; 32(11):1407-9. PubMed ID: 19928377
    [No Abstract]   [Full Text] [Related]  

  • 2. The roles of dopamine transport inhibition and dopamine release facilitation in wake enhancement and rebound hypersomnolence induced by dopaminergic agents.
    Gruner JA; Marcy VR; Lin YG; Bozyczko-Coyne D; Marino MJ; Gasior M
    Sleep; 2009 Nov; 32(11):1425-38. PubMed ID: 19928382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular Mechanisms of Amphetamines.
    Reith MEA; Gnegy ME
    Handb Exp Pharmacol; 2020; 258():265-297. PubMed ID: 31286212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of pharmacological and wake-promoting properties of the dopaminergic stimulant sydnocarb in rats.
    Gruner JA; Mathiasen JR; Flood DG; Gasior M
    J Pharmacol Exp Ther; 2011 May; 337(2):380-90. PubMed ID: 21300706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of amphetamine and modafinil on the sleep/wake cycle during experimental hypersomnia induced by sleep deprivation in the cat.
    Lin JS; Gervasoni D; Hou Y; Vanni-Mercier G; Rambert F; Frydman A; Jouvet M
    J Sleep Res; 2000 Mar; 9(1):89-96. PubMed ID: 10733694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopaminergic role in stimulant-induced wakefulness.
    Wisor JP; Nishino S; Sora I; Uhl GH; Mignot E; Edgar DM
    J Neurosci; 2001 Mar; 21(5):1787-94. PubMed ID: 11222668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine reuptake transporter (DAT) "inverse agonism"--a novel hypothesis to explain the enigmatic pharmacology of cocaine.
    Heal DJ; Gosden J; Smith SL
    Neuropharmacology; 2014 Dec; 87():19-40. PubMed ID: 24953830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modafinil induces wakefulness without intensifying motor activity or subsequent rebound hypersomnolence in the rat.
    Edgar DM; Seidel WF
    J Pharmacol Exp Ther; 1997 Nov; 283(2):757-69. PubMed ID: 9353396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychostimulant-like discriminative stimulus and locomotor sensitization properties of the wake-promoting agent modafinil in rodents.
    Paterson NE; Fedolak A; Olivier B; Hanania T; Ghavami A; Caldarone B
    Pharmacol Biochem Behav; 2010 Jun; 95(4):449-56. PubMed ID: 20346966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Social isolation rearing increases dopamine uptake and psychostimulant potency in the striatum.
    Yorgason JT; Calipari ES; Ferris MJ; Karkhanis AN; Fordahl SC; Weiner JL; Jones SR
    Neuropharmacology; 2016 Feb; 101():471-9. PubMed ID: 26525189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tamoxifen Directly Interacts with the Dopamine Transporter.
    Mikelman SR; Guptaroy B; Schmitt KC; Jones KT; Zhen J; Reith MEA; Gnegy ME
    J Pharmacol Exp Ther; 2018 Oct; 367(1):119-128. PubMed ID: 30108161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PKC phosphorylates residues in the N-terminal of the DA transporter to regulate amphetamine-induced DA efflux.
    Wang Q; Bubula N; Brown J; Wang Y; Kondev V; Vezina P
    Neurosci Lett; 2016 May; 622():78-82. PubMed ID: 27113203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of the dopamine transporter: aspects relevant to psychostimulant drugs of abuse.
    Schmitt KC; Reith ME
    Ann N Y Acad Sci; 2010 Feb; 1187():316-40. PubMed ID: 20201860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amphetamine activates Rho GTPase signaling to mediate dopamine transporter internalization and acute behavioral effects of amphetamine.
    Wheeler DS; Underhill SM; Stolz DB; Murdoch GH; Thiels E; Romero G; Amara SG
    Proc Natl Acad Sci U S A; 2015 Dec; 112(51):E7138-47. PubMed ID: 26553986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine levels of two classes of vesicles are differentially depleted by amphetamine.
    Anderson BB; Chen G; Gutman DA; Ewing AG
    Brain Res; 1998 Mar; 788(1-2):294-301. PubMed ID: 9555063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of amphetamine action revealed in mice lacking the dopamine transporter.
    Jones SR; Gainetdinov RR; Wightman RM; Caron MG
    J Neurosci; 1998 Mar; 18(6):1979-86. PubMed ID: 9482784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The dopamine transporter: a vigilant border control for psychostimulant action.
    Williams JM; Galli A
    Handb Exp Pharmacol; 2006; (175):215-32. PubMed ID: 16722238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. G protein βγ subunits play a critical role in the actions of amphetamine.
    Mauna JC; Harris SS; Pino JA; Edwards CM; DeChellis-Marks MR; Bassi CD; Garcia-Olivares J; Amara SG; Guajardo FG; Sotomayor-Zarate R; Terminel M; Castañeda E; Vergara M; Baust T; Thiels E; Torres GE
    Transl Psychiatry; 2019 Feb; 9(1):81. PubMed ID: 30745563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of environmental enrichment on dopamine and serotonin transporters and glutamate neurotransmission in medial prefrontal and orbitofrontal cortex.
    Darna M; Beckmann JS; Gipson CD; Bardo MT; Dwoskin LP
    Brain Res; 2015 Mar; 1599():115-25. PubMed ID: 25536304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behavioral effects of psychostimulants in mutant mice with cell-type specific deletion of CB2 cannabinoid receptors in dopamine neurons.
    Canseco-Alba A; Schanz N; Sanabria B; Zhao J; Lin Z; Liu QR; Onaivi ES
    Behav Brain Res; 2019 Mar; 360():286-297. PubMed ID: 30508607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.